• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Public Health . Impact of SARS-CoV-2 Alpha variant (B.1.1.7) on prisons, England

tetano

Editor, Senior Moderator
Public Health


. 2021 Dec 28;204:21-24.
doi: 10.1016/j.puhe.2021.12.018. Online ahead of print.
Impact of SARS-CoV-2 Alpha variant (B.1.1.7) on prisons, England


Amoolya Vusirikala[SUP] 1 [/SUP], Joe Flannagan[SUP] 2 [/SUP], Maciej Czachorowski[SUP] 3 [/SUP], Asad Zaidi[SUP] 2 [/SUP], Kate A Twohig[SUP] 2 [/SUP], Emma Plugge[SUP] 3 [/SUP], Nicholas Ellaby[SUP] 2 [/SUP], Wendy Rice[SUP] 2 [/SUP], Gavin Dabrera[SUP] 2 [/SUP], Dimple Y Chudasama[SUP] 2 [/SUP], Theresa Lamagni[SUP] 2 [/SUP]



Affiliations

Abstract

Objectives: Prisons are high-risk settings for infectious disease outbreaks because of their highly dynamic and crowded nature. During late 2020, prisons in England observed a surge in COVID-19 infection. This study describes the emergence of the Alpha variant in prisons during this period.
Methods: Alpha and non-Alpha variant COVID-19 cases were identified in prisoners in England using address-matched laboratory notifications and genomic information from COG-UK.
Results: Of 14,094 COVID-19-positive prisoner cases between 1 October 2020 and 28 March 2021, 11.5% (n = 1621) had sequencing results. Of these, 1082 (66.7%) were identified as the Alpha variant. Twenty-nine (2.7%) Alpha cases required hospitalisation compared with only five (1.0%; P = 0.02) non-Alpha cases. A total of 14 outbreaks were identified with the median attack rate higher for Alpha (17.9%, interquartile range [IQR] 3.2%-32.2%; P = 0.11) than non-Alpha outbreaks (3.5%, IQR 2.0%-10.2%).
Conclusion: Higher attack rates and increased likelihood of hospitalisations were observed for Alpha cases compared with non-Alpha. This suggests a key contribution to the rise in cases, hospitalisations and outbreaks in prisons in the second wave. With prisons prone to COVID-19 outbreaks and the potential to act as reservoirs for variants of concern, sequencing of prison-associated cases alongside whole-institution vaccination should be prioritised.

Keywords: COVID-19; England; Outbreaks; Prisons; Severe acute respiratory syndrome coronavirus 2; Whole-genome sequencing.
 
Back
Top Bottom